In this regard, medical interest in the AMPK system has recently increased with evidences that AMPK mediates some effects of the fat cell-derived adiponectin and antidiabetic drugs, prevents obesity-induced NAFLD, and inhibits SREBP-1c-mediated HS [31,32,33]. Here, PRKAA1 is linked to obesity due to melanocortin 4 receptor deficiency.